A Day Up For ImmunityBio Inc.
Mon, May 15, 2023 at 07:43 PM
ImmunityBio Inc. (IBRX:NASDAQ) jumped higher at $3.22, representing a gain of 41.2%. On Mon, May 15, 2023, IBRX:NASDAQ hit a New 2-Week Intraday Low of $2.25. The stock appeared on our News Catalysts scanner on Tue, Apr 25, 2023 at 10:04 AM in the 'BIOTECH' category. From Mon, May 01, 2023, the stock recorded 60.00% Up Days and 81.82% Green Days
The stock spiked on Tue, May 09, 2023 at $6.93 with a volume of 11M+.
About ImmunityBio Inc. (IBRX:NASDAQ)
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases.
Top 10 Gainers:
- NeoGames S.A. (NGMS:NASDAQ), 111.6%
- Ohmyhome Limited (OMH:NASDAQ), 67.28%
- Getaround Inc. (GETR:NYSE), 41.64%
- ImmunityBio Inc. (IBRX:NASDAQ), 41.23%
- MGO Global Inc. (MGOL:NASDAQ), 31.09%
- Sarepta Therapeutics, Inc. (SRPT:NASDAQ), 30.77%
- Vaxart, Inc. (VXRT:NASDAQ), 30.48%
- Eastside Distilling, Inc. (EAST:NASDAQ), 28.72%
- TuSimple Holdings Inc. (TSP:NASDAQ), 28.03%
- Inpixon (INPX:NASDAQ), 27.75%